New York, NY, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on October 4, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from October ...

New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on September 4, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from Septe ...

[PART 1 – FINANCIAL INFORMATION](index=4&type=section&id=PART%201%20%E2%80%93%20FINANCIAL%20INFORMATION) This section presents the unaudited condensed consolidated financial statements and management's discussion and analysis of financial condition and results of operations [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited condensed consolidated financial statements, including the balance sheets, statements of operations, changes in stockholders' deficit, and cash flows, along with detailed notes explaining the company's accounting policies, business operations, liquidity, and significant financial events [Condensed Consolidated Balance Sheets (Unaudited)](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets%20(Unaudited)%20as%20of%20June%2030%2C%202025%20and%20December%2031%2C%202024) This section provides a snapshot of the company's financial position, detailing assets, liabilities, and stockholders' deficit at specific reporting dates **Balance Sheet Highlights (June 30, 2025 vs. December 31, 2024) (in USD):** | Metric | June 30, 2025 | December 31, 2024 | Change | | :----------------------------------- | :------------ | :---------------- | :----- | | Cash | $22,170 | $253,507 | ↓ 91.25% | | Prepaid expenses | $48,046 | $96,892 | ↓ 50.41% | | Cash held in Trust Account restricted for redeeming stockholders | $2,594,214 | — | N/A | | Total current assets | $2,664,430 | $350,399 | ↑ 660.40% | | Cash held in Trust Account | $1,132,603 | $3,349,591 | ↓ 66.19% | | **TOTAL ASSETS** | **$3,797,033** | **$3,699,990** | **↑ 2.62%** | | Accounts payable | $204,675 | $79,886 | ↑ 156.22% | | Franchise tax payable | $243,506 | $209,906 | ↑ 16.01% | | Income tax payable | $522,168 | $479,279 | ↑ 8.95% | | Promissory note - related party | — | $4,445,458 | ↓ 100.00% | | Due to affiliate | $277,000 | $607,000 | ↓ 54.37% | | Convertible note - related party, net of debt discount | $4,631,437 | — | N/A | | Promissory note - third party | $450,000 | — | N/A | | Redeemed stock payable to stockholders | $2,594,214 | — | N/A | | Excise tax liability | $1,600,984 | $1,313,485 | ↑ 21.90% | | Total current liabilities | $10,523,984 | $7,135,014 | ↑ 47.52% | | Warrant liabilities | $22,800 | $2,736 | ↑ 733.33% | | Deferred underwriting fee payable | $4,025,000 | $4,025,000 | 0.00% | | **Total Liabilities** | **$14,571,784** | **$11,162,750** | **↑ 30.55%** | | Common stock subject to possible redemption | $930,037 | $3,223,514 | ↓ 71.19% | | Total Stockholders' Deficit | $(11,704,788) | $(10,686,274) | ↓ 9.53% | [Condensed Consolidated Statements of Operations (Unaudited)](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations%20(Unaudited)%20for%20the%20three%20and%20six%20months%20ended%20June%2030%2C%202025%20and%202024) This section presents the company's financial performance over specific periods, detailing revenues, expenses, and net loss **Statements of Operations Highlights (Three Months Ended June 30, 2025 vs. 2024) (in USD):** | Metric | June 30, 2025 | June 30, 2024 | Change | | :----------------------------------- | :------------ | :------------ | :----- | | General and administrative expenses | $333,827 | $419,611 | ↓ 20.44% | | Provision (reversal) for franchise tax expense | $(16,400) | $50,000 | ↓ 132.80% | | Total operating expenses | $(317,427) | $(469,611) | ↓ 32.39% | | Income on cash held in Trust Account | $34,237 | $344,645 | ↓ 90.08% | | Taxes penalties and interest | $(133,677) | — | N/A | | Interest expense | $(451,629) | $(43,602) | ↑ 935.02% | | Change in fair value of warrant liabilities | $(18,525) | $(14,820) | ↑ 25.00% | | Total other (loss) income, net | $(569,594) | $286,223 | ↓ 298.93% | | Loss before provision for income taxes | $(887,021) | $(183,388) | ↑ 383.69% | | Provision for income taxes | $(6,875) | $(33,797) | ↓ 79.63% | | **NET LOSS** | **$(893,896)** | **$(217,185)** | **↑ 311.50%** | | Basic and diluted net income per share, Common stock – redeemable | $0.35 | $0.06 | ↑ 483.33% | | Basic and diluted net income (loss) per share, Common stock – non-redeemable | $(0.28) | $(0.11) | ↑ 154.55% | **Statements of Operations Highlights (Six Months Ended June 30, 2025 vs. 2024) (in USD):** | Metric | June 30, 2025 | June 30, 2024 | Change | | :----------------------------------- | :------------ | :------------ | :----- | | General and administrative expenses | $604,083 | $1,023,082 | ↓ 40.95% | | Provision (reversal) for franchise tax expense | $33,600 | $43,662 | ↓ 23.04% | | Total operating expenses | $(637,683) | $(1,066,744) | ↓ 40.23% | | Income on cash held in Trust Account | $66,336 | $687,312 | ↓ 90.35% | | Taxes penalties and interest | $(297,339) | $(2,356) | ↑ 12596.05% | | Interest expense | $(736,826) | $(76,997) | ↑ 856.83% | | Change in fair value of warrant liabilities | $(20,064) | $(26,619) | ↓ 24.62% | | Total other (loss) income, net | $(987,893) | $581,340 | ↓ 270.00% | | Loss before provision for income taxes | $(1,625,576) | $(485,404) | ↑ 234.80% | | Provision for income taxes | $(6,875) | $(107,088) | ↓ 93.58% | | **NET LOSS** | **$(1,632,451)** | **$(592,492)** | **↑ 175.54%** | | Basic and diluted net income per share, Common stock – redeemable | $0.69 | $0.10 | ↑ 590.00% | | Basic and diluted net income (loss) per share, Common stock – non-redeemable | $(0.52) | $(0.25) | ↑ 108.00% | [Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Changes%20in%20Stockholders'%20Deficit%20(Unaudited)%20for%20the%20three%20and%20six%20months%20ended%20June%2030%2C%202025%20and%202024) This section outlines the changes in the company's equity over specific periods, reflecting net loss and other comprehensive income/loss **Stockholders' Deficit (June 30, 2025 vs. December 31, 2024) (in USD):** | Metric | June 30, 2025 | December 31, 2024 | | :-------------------------- | :------------ | :---------------- | | Total Stockholders' Deficit | $(11,704,788) | $(10,686,274) | - **Key Changes (Six Months Ended June 30, 2025):** * Gain on modification of terms of promissory notes and advances from affiliate: **$940,847**[12](index=12&type=chunk) * Remeasurement of common stock subject to redemption: **$(162,099)** (March 31, 2025) and **$(138,638)** (June 30, 2025)[12](index=12&type=chunk) * Net loss: **$(738,555)** (March 31, 2025) and **$(893,896)** (June 30, 2025)[12](index=12&type=chunk) * Excise tax liability in connection with redemption: **$(26,173)**[12](index=12&type=chunk) [Condensed Consolidated Statements of Cash Flows (Unaudited)](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows%20(Unaudited)%20for%20the%20six%20months%20ended%20June%2030%2C%202025%20and%202024) This section details the inflows and outflows of cash from operating, investing, and financing activities over specific periods **Cash Flow Highlights (Six Months Ended June 30, 2025 vs. 2024) (in USD):** | Metric | June 30, 2025 | June 30, 2024 | Change | | :----------------------------------- | :------------ | :------------ | :----- | | Net cash used in operating activities | $(430,447) | $(1,559,688) | ↓ 72.41% | | Net cash (used in) provided by investing activities | $(310,890) | $73,768 | ↓ 521.44% | | Net cash provided by financing activities | $510,000 | $1,550,000 | ↓ 67.10% | | **NET CHANGE IN CASH** | **$(231,337)** | **$64,080** | **↓ 461.00%** | | CASH, BEGINNING OF PERIOD | $253,507 | $79,073 | ↑ 220.59% | | **CASH, END OF PERIOD** | **$22,170** | **$143,153** | **↓ 84.51%** | - **Non-cash investing and financing activities (Six Months Ended June 30, 2025):** * Remeasurement of Common stock subject to redemption: **$300,737**[16](index=16&type=chunk) * Gain on modification of terms of promissory notes and advances from affiliate: **$940,847**[16](index=16&type=chunk) * Excise tax accrued for common stock redemption: **$26,173**[16](index=16&type=chunk) [Notes to Condensed Consolidated Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements%20(Unaudited)) This section provides detailed explanations and additional information supporting the condensed consolidated financial statements [Note 1 – Description of Organization and Business Operations and Liquidity](index=8&type=section&id=Note%201%20%E2%80%93%20Description%20of%20Organization%20and%20Business%20Operations%20and%20Liquidity) Globalink Investment Inc. is a blank check company formed in March 2021 to pursue a business combination. It has not commenced operations and generates non-operating income from interest on its Trust Account. The company faces significant liquidity challenges with a working capital deficit of $7.9 million as of June 30, 2025, and a going concern uncertainty if a business combination is not completed by September 9, 2025 (extendable to December 9, 2025). The company is actively pursuing a merger with Alps Global Holding Pubco and Alps Life Sciences Inc - **Company Status**: Blank check company formed March 24, 2021, for a Business Combination; no operating revenues until completion of Business Combination[17](index=17&type=chunk)[20](index=20&type=chunk) - **IPO Details**: Consummated IPO on December 9, 2021, raising **$100,000,000** from **10,000,000** units at **$10.00**/unit. Additional **$15,000,000** from over-allotment option[20](index=20&type=chunk)[22](index=22&type=chunk) - **Trust Account**: **$116,725,000** initially placed in Trust Account, invested in U.S. government securities, but converted to cash in July 2023 to mitigate investment company risk[25](index=25&type=chunk)[26](index=26&type=chunk) - **Redemptions & Extensions**: * March 6, 2023: **6,756,695** shares redeemed for ~**$69.92 million**[37](index=37&type=chunk) * November 28, 2023: **2,180,738** shares redeemed for ~**$23.60 million**[40](index=40&type=chunk) * December 3, 2024: **2,285,056** shares redeemed for ~**$26.89 million** (overpayment of **$563,108** identified)[43](index=43&type=chunk) * June 4, 2025: **204,910** shares redeemed for ~**$2.6 million** (overpayment of **$23,067** identified)[45](index=45&type=chunk)[46](index=46&type=chunk) * Termination Date extended to September 9, 2025, with options to extend to December 9, 2025[65](index=65&type=chunk) - **Nasdaq Delisting**: Received delisting notice on December 10, 2024, for failing to complete a business combination within 36 months. Securities suspended from trading on Nasdaq on December 17, 2024, and delisting became effective May 19, 2025. Now quoted on OTC Pink[48](index=48&type=chunk)[49](index=49&type=chunk) - **Business Combination**: Entered Merger Agreement with Alps Global Holding Pubco and Alps Life Sciences Inc. on January 30, 2024, amended multiple times[51](index=51&type=chunk) - **PIPE Investment**: Initial **$40.2 million** PIPE agreements terminated; new agreements for **$3,279,911**, with **$1,124,361** received as of June 30, 2025[52](index=52&type=chunk)[53](index=53&type=chunk) - **Liquidity & Going Concern**: Cash of **$22,170** and working capital deficit of ~**$7.9 million** as of June 30, 2025. Substantial doubt about ability to continue as a going concern due to mandatory liquidation if business combination not completed by September 9, 2025 (or December 9, 2025 with extensions)[62](index=62&type=chunk)[65](index=65&type=chunk) - **Excise Tax**: Subject to a **1%** excise tax on stock repurchases after December 31, 2022. Recorded **$1,600,984** excise tax liability (including interest and penalties) as of June 30, 2025[58](index=58&type=chunk)[59](index=59&type=chunk)[89](index=89&type=chunk) [Note 2 – Summary of Significant Accounting Policies](index=16&type=section&id=Note%202%20%E2%80%93%20Summary%20of%20Significant%20Accounting%20Policies) This note outlines the company's accounting policies, including basis of presentation, principles of consolidation, emerging growth company status, use of estimates, cash held in Trust Account, concentration of credit risk, fair value measurements, debt modification/extinguishment, convertible debt, income taxes, excise tax, common stock subject to redemption, net income (loss) per share, accounting for warrants, and recent accounting pronouncements - **Basis of Presentation**: Unaudited condensed consolidated financial statements prepared in conformity with U.S. GAAP and SEC rules for interim reporting[67](index=67&type=chunk) - **Emerging Growth Company**: Elected not to opt out of the extended transition period for new accounting standards, allowing adoption at private company dates[70](index=70&type=chunk) - **Cash Held in Trust Account**: All assets in Trust Account held in cash since July 2023 to mitigate investment company risk[72](index=72&type=chunk)[73](index=73&type=chunk) - **Income Taxes**: Effective tax rate was **(0.78)%** for Q2 2025 and **(0.42)%** for H1 2025, differing from the **21%** statutory rate due to penalties, interest on excise tax, business combination expenses, warrant fair value changes, and debt discount amortization[83](index=83&type=chunk) - **Excise Tax Liability**: Recorded **$1,600,984** as of June 30, 2025, including **$370,693** in interest and penalties, for the **1%** excise tax on stock repurchases[89](index=89&type=chunk) - **Common Stock Subject to Redemption**: Classified as temporary equity due to redemption features outside the company's control[91](index=91&type=chunk) - **Accounting for Warrants**: Public Warrants are equity-classified; Private Placement Warrants are liability-classified and re-measured at fair value each period, with changes recognized in operations[102](index=102&type=chunk)[103](index=103&type=chunk) - **Recent Accounting Pronouncements**: Adopted ASU 2023-07 (Segment Reporting) for FY2024; evaluating ASU 2023-09 (Income Tax Disclosures) effective FY2025[104](index=104&type=chunk)[106](index=106&type=chunk) [Note 3 – Initial Public Offering and Over-allotment](index=26&type=section&id=Note%203%20%E2%80%93%20Initial%20Public%20Offering%20and%20Over-allotment) Details the IPO and over-allotment, where the company sold 11,500,000 units at $10.00 each, generating $115,000,000. Each unit included one common stock, one redeemable warrant (for 1/2 share at $11.50), and one right (for 1/10 share) - **IPO Units Sold**: **11,500,000** units at **$10.00** per unit[107](index=107&type=chunk) - **Gross Proceeds**: **$115,000,000**[107](index=107&type=chunk) - **Unit Composition**: One common stock, one redeemable warrant (1/2 share at **$11.50**), one right (1/10 share)[107](index=107&type=chunk) [Note 4 – Private Placement](index=26&type=section&id=Note%204%20%E2%80%93%20Private%20Placement) The company issued and sold 570,000 Private Placement Units at $10.00 per unit, generating $5,700,000 in gross proceeds. These units, sold to a related party, include one share, one Private Placement Warrant, and one right. Proceeds were added to the Trust Account - **Private Placement Units Sold**: **570,000** units at **$10.00** per unit[108](index=108&type=chunk) - **Gross Proceeds**: **$5,700,000**[108](index=108&type=chunk) - **Unit Composition**: One share, one Private Placement Warrant (1/2 share at **$11.50**), one right (1/10 share)[108](index=108&type=chunk) - **Purchaser**: Public Gold Marketing Sdn. Bhd., a related party[108](index=108&type=chunk) [Note 5 – Related Party Transactions](index=26&type=section&id=Note%205%20%E2%80%93%20Related%20Party%20Transactions) This note details transactions with related parties, including the initial purchase of Founder Shares by the sponsor, the private placement of units to Public Gold Marketing Sdn. Bhd., and various promissory notes and advances from Public Gold Marketing Sdn. Bhd. and an affiliate of the sponsor. It also covers the termination of an administrative services agreement - **Founder Shares**: Sponsor purchased **2,875,000** shares for **$25,000** on August 19, 2021, subject to transfer restrictions[109](index=109&type=chunk)[110](index=110&type=chunk) - **Private Placement**: **570,000** Private Placement Units sold to Public Gold Marketing Sdn. Bhd. (a related party) for **$5,700,000**[111](index=111&type=chunk) - **Related Party Loans (Promissory Notes)**: * Multiple promissory notes with Public Gold Marketing Sdn. Bhd. (related party) for extension fees and working capital, bearing **6%** interest[113](index=113&type=chunk) * Total principal and interest from these notes: **$4,570,422** as of June 30, 2025 (vs. **$4,445,458** as of December 31, 2024)[137](index=137&type=chunk)[138](index=138&type=chunk] * March 6, 2025 amendment: **$2 million** of outstanding balance due in cash post-closing, remaining converted to PubCo ordinary shares at **$10.00**/share. Resulted in a gain on modification of **$880,656**[139](index=139&type=chunk)[140](index=140&type=chunk) - **Advances from Affiliate**: * **$390,000** advanced by an affiliate of the sponsor for Trust Account extensions[116](index=116&type=chunk) * March 24, 2025 amendment: **$390,000** advance converted to PubCo ordinary shares at **$10.00**/share at closing. Resulted in a gain on modification of **$60,191**[117](index=117&type=chunk) * **$60,000** advance from CEO for trust extension deposits[117](index=117&type=chunk) - **Administrative Services Agreement**: Terminated on September 30, 2023. **$217,000** accrued under "Due to affiliate" as of June 30, 2025[114](index=114&type=chunk)[115](index=115&type=chunk) [Note 6 – Commitments and Contingencies](index=28&type=section&id=Note%206%20%E2%80%93%20Commitments%20and%20Contingencies) This note outlines the company's commitments and contingencies, including registration rights for certain security holders and the deferred underwriting fees. It details an amendment to the underwriting agreement where deferred fees and M&A fees will be satisfied by a transfer of Alps Holdco Shares - **Registration Rights**: Holders of Founder Shares, Private Placement Units, and warrants from Working Capital Loans are entitled to registration rights[120](index=120&type=chunk) - **Underwriting Agreement**: * Deferred underwriting discounts of **$4,025,000** payable upon Business Combination[121](index=121&type=chunk) * May 22, 2025 Amendment: Total Fee Amount of **$5,025,000** (deferred underwriting + **$1,000,000** M&A fee) to be satisfied by transfer of **4,187,500** Alps Holdco Shares to Chardan prior to business combination closing (by July 31, 2025)[122](index=122&type=chunk) [Note 7 – Promissory Notes – Related Party](index=29&type=section&id=Note%207%20%E2%80%93%20Promissory%20Notes%20%E2%80%93%20Related%20Party) This note provides detailed information on various promissory notes entered into with Public Gold Marketing Sdn. Bhd., a related party, for extension fees and working capital. These notes bear 6% interest and are repayable upon a business combination. An amendment on March 6, 2025, converted a portion of the outstanding balance into PubCo shares and made $2 million payable in cash, resulting in a significant gain on modification - **Promissory Notes with Public Gold Marketing Sdn. Bhd.**: Multiple notes totaling **$4,570,422** (principal + interest) as of June 30, 2025, bearing **6%** interest, repayable upon Business Combination[123](index=123&type=chunk)[124](index=124&type=chunk)[126](index=126&type=chunk)[127](index=127&type=chunk)[128](index=128&type=chunk)[129](index=129&type=chunk)[130](index=130&type=chunk)[131](index=131&type=chunk)[132](index=132&type=chunk)[133](index=133&type=chunk)[134](index=134&type=chunk)[135](index=135&type=chunk)[136](index=136&type=chunk)[137](index=137&type=chunk) - **March 6, 2025 Amendment**: **$2 million** of outstanding balance due in cash post-closing; remaining balance converted to PubCo ordinary shares at **$10.00**/share[138](index=138&type=chunk)[139](index=139&type=chunk) - **Gain on Modification**: **$880,656** gain recognized due to the amendment[140](index=140&type=chunk) - **Amortization of Debt Discount**: **$358,947** (Q2 2025) and **$576,931** (H1 2025) recorded as interest expense[140](index=140&type=chunk) **Valuation Assumptions for Convertible Note (March 6, 2025):** | Assumption | Value | | :----------------------- | :------ | | Closing stock price | $12.00 | | Expected time to liquidity | 0.37 years | | Risk free rate | 4.31% | | Volatility | 27.7% | [Note 8 – Promissory Note - Third Party](index=32&type=section&id=Note%208%20%E2%80%93%20Promissory%20Note%20-%20Third%20Party) The company entered into two non-interest bearing promissory notes with Dr. Tham Seng Kong, a party to the Merger Agreement, for working capital. As of June 30, 2025, $450,000 had been borrowed, with an additional $200,000 withdrawn subsequently, bringing the total to $650,000 - **Promissory Notes**: Two non-interest bearing notes with Dr. Tham Seng Kong (Merger Agreement party) for working capital[144](index=144&type=chunk) - **Amount Borrowed**: **$450,000** as of June 30, 2025[144](index=144&type=chunk) - **Subsequent Withdrawal**: Additional **$200,000** withdrawn after June 30, 2025, totaling **$650,000**[169](index=169&type=chunk) [Note 9 – Stockholders' Deficit](index=32&type=section&id=Note%209%20%E2%80%93%20Stockholders'%20Deficit) This note details the company's common stock, warrants, and rights. It specifies the number of authorized and outstanding common shares, the types and terms of public and private warrants (including exercise conditions and redemption features), and the automatic conversion of public rights into common stock upon a business combination - **Common Stock**: **500,000,000** shares authorized; **3,445,000** shares issued and outstanding (excluding redeemable shares) as of June 30, 2025 and December 31, 2024[145](index=145&type=chunk) - **Warrants Outstanding**: **11,500,000** Public Warrants and **570,000** Private Placement Warrants as of June 30, 2025 and December 31, 2024[146](index=146&type=chunk) - **Public Warrants**: Exercisable after Business Combination, expire five years post-combination, redeemable by company if common stock price exceeds **$16.50**[147](index=147&type=chunk)[148](index=148&type=chunk)[149](index=149&type=chunk) - **Private Placement Warrants**: Substantially similar to Public Warrants but exercisable for cash or cashless at holder's option, and not redeemable by the company as long as held by initial purchasers/permitted transferees[151](index=151&type=chunk) - **Rights**: Each Public Right automatically converts to one-tenth of one common share upon Business Combination[155](index=155&type=chunk) [Note 10 – Fair Value Measurements](index=34&type=section&id=Note%2010%20%E2%80%93%20Fair%20Value%20Measurements) This note explains the fair value hierarchy used for financial instruments, classifying assets and liabilities based on observable and unobservable inputs. It specifically details the valuation of Private Placement Warrants as Level 2 liabilities, using the observable price of public warrants as a benchmark - **Fair Value Hierarchy**: Uses Level 1 (quoted prices in active markets), Level 2 (observable inputs other than Level 1), and Level 3 (unobservable inputs)[157](index=157&type=chunk)[158](index=158&type=chunk) - **Private Placement Warrants Valuation**: Classified as Level 2 liabilities, valued using the observable price for public warrants as a benchmark[160](index=160&type=chunk)[161](index=161&type=chunk) **Fair Value of Private Placement Warrants (in USD):** | Date | Fair Value | | :----------------------- | :--------- | | June 30, 2025 | $22,800 | | December 31, 2024 | $2,736 | | Change in valuation inputs or other assumptions (Q2 2025) | $18,525 | | Change in valuation inputs or other assumptions (H1 2025) | $20,064 | [Note 11 – Segment Information](index=36&type=section&id=Note%2011%20%E2%80%93%20Segment%20Information) The company operates as a single segment, as it is a blank check company with no operations, and its Chief Executive Officer (CODM) reviews consolidated operating results to allocate resources and assess performance. Key metrics reviewed include interest earned on the Trust Account and formation/operating expenses, particularly professional service fees related to the Business Combination - **Single Operating Segment**: The company is a blank check company with no operations, thus has only one operating segment[163](index=163&type=chunk)[164](index=164&type=chunk)[165](index=165&type=chunk) - **CODM**: Chief Executive Officer reviews consolidated operating results[165](index=165&type=chunk) - **Key Performance Metrics**: Interest earned on Trust Account, professional service fees for Business Combination, and other general and administrative expenses[166](index=166&type=chunk) **Operating Expenses (Six Months Ended June 30) (in USD):** | Metric | 2025 | 2024 | Change | | :------------------------------------------ | :--------- | :--------- | :----- | | Professional service fee in connection with Business Combination | $(175,328) | $(558,504) | ↓ 68.60% | | Franchise tax expense | $(33,600) | $(43,662) | ↓ 23.04% | | Other general and administrative expenses and tax expenses | $(428,755) | $(464,578) | ↓ 7.60% | | **Total operating expenses** | **$(637,683)** | **$(1,066,744)** | **↓ 40.23%** | | Income on cash held in Trust Account | $66,336 | $687,312 | ↓ 90.35% | [Note 12 – Subsequent Events](index=36&type=section&id=Note%2012%20%E2%80%93%20Subsequent%20Events) This note discloses events occurring after June 30, 2025, including additional deposits into the Trust Account to extend the termination date, further withdrawals under a third-party promissory note, tax withdrawals from the Trust Account, and the payment of redeeming shareholders from the June 2025 Special Meeting, which involved an identified overpayment - **Trust Account Extensions**: **$21,780** deposited in July and August 2025, extending Termination Date to September 9, 2025[168](index=168&type=chunk) - **Third-Party Promissory Note**: Additional **$200,000** withdrawn by Dr. Tham Seng Kong, bringing total outstanding to **$650,000**[169](index=169&type=chunk) - **Tax Withdrawals**: **$178,491** permitted tax withdrawal from Trust Account in July and August 2025[170](index=170&type=chunk) - **Redemption Payments**: **$2,617,281** paid to June 2025 redeeming shareholders, with an identified overpayment of **$23,067** (**$0.11** per share) that the company will attempt to recover[171](index=171&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=38&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on the company's financial condition and operational results, highlighting its status as a blank check company seeking a business combination. It discusses recent developments including redemptions, extensions, the ongoing merger agreement with Alps Holdco, PIPE investments, Nasdaq delisting, and the company's liquidity challenges and going concern risk [Overview](index=38&type=section&id=Overview) This section provides a general introduction to the company's purpose as a blank check company and the inherent risks associated with its business model - **Company Purpose**: Formed March 24, 2021, as a blank check company to effect a business combination[174](index=174&type=chunk) - **Target Focus**: Medical technology and green energy industries in North America, Europe, Southeast Asia, and Asia (excluding mainland China, Hong Kong, Macau)[174](index=174&type=chunk) - **Acquisition Method**: Combination of cash (from Trust Account or financing) or equity securities[174](index=174&type=chunk) - **Risks of Additional Share Issuance**: * May significantly dilute the equity interest of investors[175](index=175&type=chunk) * May subordinate the rights of common stock holders if preferred stock is issued[175](index=175&type=chunk) * Could cause a change in control, affecting net operating loss carry forwards and potentially leading to officer/director resignations[175](index=175&type=chunk) * May delay or prevent a change of control by diluting stock ownership[175](index=175&type=chunk) * May adversely affect prevailing market prices for common stock, rights, and/or warrants[175](index=175&type=chunk) - **Risks of Significant Debt**: * Default and foreclosure on assets if operating revenues are insufficient[175](index=175&type=chunk) * Acceleration of obligations if covenants are breached[175](index=175&type=chunk) * Immediate payment of principal and interest if debt is payable on demand[177](index=177&type=chunk) * Inability to obtain necessary additional financing due to restrictive covenants[177](index=177&type=chunk) * Substantial portion of cash flow used for debt, reducing funds for dividends, expenses, capital expenditures, and acquisitions[177](index=177&type=chunk) * Limitations on flexibility in business planning and reaction to industry changes[177](index=177&type=chunk) * Increased vulnerability to adverse economic, industry, competitive, and regulatory changes[177](index=177&type=chunk) * Limitations on borrowing additional amounts for various purposes[177](index=177&type=chunk) [Recent Developments](index=40&type=section&id=Recent%20Developments) This section highlights key events and changes impacting the company, including share redemptions, extension of the business combination deadline, and Nasdaq delisting - **Redemptions**: * December 2024 Special Meeting: **2,285,056** shares redeemed for ~**$26.89 million**; identified overpayment of **$563,108**[179](index=179&type=chunk) * June 2025 Special Meeting: **204,910** shares redeemed for ~**$2.6 million**; identified overpayment of **$23,067**[182](index=182&type=chunk) - **Extensions**: Termination Date extended to September 9, 2025, with options to extend to December 9, 2025, through monthly deposits into the Trust Account[180](index=180&type=chunk)[181](index=181&type=chunk)[183](index=183&type=chunk) - **Business Combination**: Merger Agreement with Alps Global Holding Pubco and Alps Life Sciences Inc. entered January 30, 2024, and amended multiple times[184](index=184&type=chunk)[185](index=185&type=chunk) - **Merger Agreement Amendments**: * Removed earn-out provision[188](index=188&type=chunk) * Removed **$5,000,001** net tangible asset requirement for Globalink and PubCo (if PubCo satisfies Nasdaq listing)[188](index=188&type=chunk) * Removed Nasdaq listing as a condition to closing[188](index=188&type=chunk) - **PIPE Agreements**: Initial **$40.2 million** subscriptions terminated; new agreements for **$3,279,911**, with **$1,124,361** received in escrow[186](index=186&type=chunk)[187](index=187&type=chunk) - **Nasdaq Delisting**: Delisting notice received December 10, 2024, for non-compliance with business combination timeline. Securities suspended December 17, 2024, delisting effective May 19, 2025. Now quoted on OTC Pink[191](index=191&type=chunk)[192](index=192&type=chunk) - **Continuation of Merger**: Company expects to proceed with the Merger Agreement despite delisting[193](index=193&type=chunk) [Results of Operations](index=42&type=section&id=Results%20of%20Operations) This section analyzes the company's financial performance, focusing on the primary drivers of net loss and changes in income from the Trust Account - **Net Loss (Three Months Ended June 30):** * 2025: **$(893,896)**[195](index=195&type=chunk) * 2024: **$(217,185)**[195](index=195&type=chunk) * Increase in net loss primarily due to higher interest expense (**$451,629** in 2025 vs. **$43,602** in 2024) and tax penalties/interest (**$133,677** in 2025 vs. **$0** in 2024), despite lower general and administrative expenses and a franchise tax expense reversal[197](index=197&type=chunk) - **Net Loss (Six Months Ended June 30):** * 2025: **$(1,632,451)**[196](index=196&type=chunk) * 2024: **$(592,492)**[196](index=196&type=chunk) * Increase in net loss primarily due to significantly higher interest expense (**$736,826** in 2025 vs. **$76,997** in 2024) and tax penalties/interest (**$297,339** in 2025 vs. **$2,356** in 2024), partially offset by lower general and administrative expenses[198](index=198&type=chunk) - **Trust Account Income**: Decreased significantly from **$344,645** (Q2 2024) to **$34,237** (Q2 2025) and from **$687,312** (H1 2024) to **$66,336** (H1 2025)[195](index=195&type=chunk)[196](index=196&type=chunk)[197](index=197&type=chunk)[198](index=198&type=chunk) [Liquidity, Capital Resources and Going Concern](index=43&type=section&id=Liquidity%2C%20Capital%20Resources%20and%20Going%20Concern) This section assesses the company's ability to meet its short-term and long-term obligations, detailing its cash position, financing activities, and the ongoing risk to its continued operations - **IPO Proceeds**: **$100,000,000** from IPO, **$5,175,000** from private placement, and **$15,000,000** from over-allotment option[199](index=199&type=chunk)[200](index=200&type=chunk) - **Offering Costs**: **$6,887,896**, including **$4,025,000** deferred underwriting fees contingent on business combination[201](index=201&type=chunk) - **Trust Account**: **$116,725,000** initially placed, now held in cash since July 2023[202](index=202&type=chunk)[203](index=203&type=chunk) **Cash Flow from Operations (Six Months Ended June 30) (in USD):** | Metric | 2025 | 2024 | Change | | :----------------------------------- | :--------- | :----------- | :----- | | Net cash used in operating activities | $(430,447) | $(1,559,688) | ↓ 72.41% | - **Cash Balances**: * Cash held in Trust Account: **$3,726,817** (including **$2,594,214** redeemed stock payable) as of June 30, 2025[206](index=206&type=chunk) * Cash outside Trust Account: **$22,170** as of June 30, 2025 (vs. **$253,507** as of December 31, 2024)[208](index=208&type=chunk) - **Promissory Notes (Related Party)**: * Total principal and interest owed to related parties: **$4,570,422** as of June 30, 2025 (vs. **$4,445,458** as of December 31, 2024)[224](index=224&type=chunk) * March 6, 2025 amendment: **$2 million** payable in cash, remaining converted to PubCo shares[225](index=225&type=chunk) * Debt discount amortization: **$358,947** (Q2 2025) and **$576,931** (H1 2025) recorded as interest expense[238](index=238&type=chunk) - **Promissory Notes (Third Party)**: * Total owed to third party: **$450,000** as of June 30, 2025 (vs. nil as of December 31, 2024)[226](index=226&type=chunk) * Subsequent withdrawal: Additional **$200,000**, bringing total to **$650,000**[240](index=240&type=chunk) - **Going Concern**: Substantial doubt exists due to mandatory liquidation if business combination not completed by September 9, 2025 (or December 9, 2025 with extensions) and current liquidity condition[231](index=231&type=chunk) [Off-Balance Sheet Arrangements](index=48&type=section&id=Off-Balance%20Sheet%20Arrangements) This section confirms the absence of any off-balance sheet obligations, assets, or liabilities for the company - The company has no off-balance sheet obligations, assets, or liabilities as of June 30, 2025, and December 31, 2024[232](index=232&type=chunk) [Contractual Obligations](index=48&type=section&id=Contractual%20Obligations) This section states that the company has no long-term contractual obligations, including debt or lease liabilities - The company has no long-term debt, capital lease obligations, operating lease obligations, or long-term liabilities[233](index=233&type=chunk) [Registration Rights](index=48&type=section&id=Registration%20Rights) This section details the registration rights granted to certain security holders, allowing them to register their shares for resale - Holders of insider shares, private units, and units from working capital/extension loans have registration rights, entitling them to demand and "piggy-back" registration[234](index=234&type=chunk) [Underwriting Agreement](index=48&type=section&id=Underwriting%20Agreement) This section outlines the deferred underwriting fees and the amendment regarding their satisfaction through a transfer of Alps Holdco Shares - Deferred underwriting discounts of **$4,025,000** are payable upon completion of a business combination[235](index=235&type=chunk) - An amendment on May 22, 2025, states that a total Fee Amount of **$5,025,000** (including **$1,000,000** M&A fee) will be satisfied by the transfer of **4,187,500** Alps Holdco Shares to Chardan prior to the business combination closing[236](index=236&type=chunk) [Right of First Refusal](index=48&type=section&id=Right%20of%20First%20Refusal) This section describes the right of first refusal granted to Chardan Capital Markets, LLC for future financing and M&A transactions - Chardan Capital Markets, LLC has a right of first refusal for future financings and M&A transactions for 12 months after the business combination, limited to three years from the IPO registration statement effective date[237](index=237&type=chunk) [Promissory Notes](index=48&type=section&id=Promissory%20Notes) This section summarizes the company's obligations under related-party and third-party promissory notes, including recent amendments - **Related Party Notes**: Aggregate principal and interest owed to related parties was **$4,570,422** as of June 30, 2025 (vs. **$4,445,458** as of December 31, 2024)[238](index=238&type=chunk) - **Amendments**: Terms amended on March 6, 2025, and March 24, 2025, leading to a debt discount amortized over the expected term[239](index=239&type=chunk) - **Third-Party Notes**: **$450,000** owed to a third party (Dr. Tham Seng Kong) as of June 30, 2025, which is non-interest bearing[240](index=240&type=chunk) [Jumpstart Our Business Startups Act of 2012 (the "JOBS Act")](index=49&type=section&id=Jumpstart%20Our%20Business%20Startups%20Act%20of%202012%20(the%20%22JOBS%20Act%22)) This section explains the company's status as an emerging growth company under the JOBS Act and its election to delay adoption of new accounting standards - The company qualifies as an "emerging growth company" under the JOBS Act[241](index=241&type=chunk) - It has elected to delay the adoption of new or revised accounting standards, aligning with private company effective dates[241](index=241&type=chunk) - The company is evaluating other reduced reporting requirements, such as exemptions from auditor's attestation report on internal controls, certain compensation disclosures, PCAOB rules, and executive compensation correlation disclosures[243](index=243&type=chunk) [Critical Estimates](index=50&type=section&id=Critical%20Estimates) This section discusses key accounting estimates, particularly the classification and fair value measurement of warrants and the evaluation of new accounting pronouncements - **Accounting for Warrants**: Warrants are classified as equity or liability based on specific terms and ASC 480/815. Private warrants are liability-classified and re-measured at fair value each period, with changes recognized in operations[245](index=245&type=chunk) - **Recent Accounting Pronouncements**: Management is evaluating the impact of ASU 2023-09 (Income Tax Disclosures), effective for fiscal years beginning after December 15, 2024[246](index=246&type=chunk) [Item 3. Quantitative and Qualitative Disclosures about Market Risk](index=50&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) As a smaller reporting company, Globalink Investment Inc. is not required to provide quantitative and qualitative disclosures about market risk - The company is a smaller reporting company and is exempt from providing disclosures on market risk[247](index=247&type=chunk) [Item 4. Controls and Procedures](index=50&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were not effective as of June 30, 2025, primarily due to material weaknesses related to the reclassification of private warrants, non-compliance with timely tax filings, and incorrect reporting of common stock subject to redemption and redemption price per share. The company plans to enhance processes, access to accounting literature, and internal communication to remediate these issues - **Disclosure Controls and Procedures Effectiveness**: Not effective as of June 30, 2025[249](index=249&type=chunk) - **Material Weaknesses Identified**: * Controls related to reclassification of private warrants (complex financial instruments)[249](index=249&type=chunk) * Lack of compliance control for timely tax return filings[249](index=249&type=chunk) * Revisions to earnings per share[249](index=249&type=chunk) * Incorrect reporting of common stock subject to possible redemption and redemption price per share[249](index=249&type=chunk) - **Remediation Plans**: Enhance processes, provide enhanced access to accounting literature and research, increase communication among personnel and third-party professionals, and implement deeper review of common stock subject to possible redemption[251](index=251&type=chunk) - **No Material Changes in Internal Control**: No changes in internal control over financial reporting during the quarter that materially affected or are reasonably likely to materially affect it[251](index=251&type=chunk) [PART II – OTHER INFORMATION](index=52&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) This section provides additional information not covered in the financial statements, including legal proceedings, risk factors, and exhibits [Item 1. Legal Proceedings](index=52&type=section&id=Item%201.%20Legal%20Proceedings) The company reported no legal proceedings - No legal proceedings[253](index=253&type=chunk) [Item 1A. Risk Factors](index=52&type=section&id=Item%201A.Risk%20Factors) As a smaller reporting company, Globalink Investment Inc. is not required to provide disclosures under this item in its quarterly report, referring instead to the comprehensive list of risk factors in its annual report on Form 10-K - As a smaller reporting company, the company is not required to provide risk factor disclosures in this quarterly report[254](index=254&type=chunk) - Comprehensive risk factors are available in the annual report on Form 10-K for the fiscal year ended December 31, 2024[254](index=254&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=52&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities and use of proceeds - No unregistered sales of equity securities and use of proceeds to report[255](index=255&type=chunk) [Item 3. Defaults Upon Senior Securities](index=52&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon senior securities - No defaults upon senior securities to report[256](index=256&type=chunk) [Item 4. Mine Safety Disclosures](index=52&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - Not applicable[257](index=257&type=chunk) [Item 5. Other Information](index=52&type=section&id=Item%205.%20Other%20Information) The company reported no other information - No other information to report[258](index=258&type=chunk) [Item 6. Exhibits](index=53&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed as part of, or incorporated by reference into, the Quarterly Report on Form 10-Q, including various certificates of incorporation, bylaws, specimen certificates, agreements, and certifications - Lists various corporate documents, agreements, and certifications filed or incorporated by reference[260](index=260&type=chunk)[261](index=261&type=chunk) - Includes certifications of Principal Executive Officer and Principal Financial Officer pursuant to Sarbanes-Oxley Act[261](index=261&type=chunk) [SIGNATURES](index=54&type=section&id=SIGNATURES) The report is signed by Say Leong Lim, Chief Executive Officer, Chief Financial Officer, and Director of Globalink Investment Inc., on August 26, 2025 - Signed by Say Leong Lim, CEO, CFO, and Director[266](index=266&type=chunk) - Date of signature: August 26, 2025[266](index=266&type=chunk)

Company Overview - Globalink Investment Inc. is a special purpose acquisition company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [2] - The company has no restrictions on the industry or geographic region for its targets, but intends to focus on the medical technology and green energy sectors in North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) [2] Recent Developments - On August 5, 2025, Globalink deposited $0.15 per public share, totaling $10,890.15, into its trust account to extend the deadline for completing its initial business combination from August 9, 2025, to September 9, 2025 [1] - This extension marks the twenty-sixth extension since the company's initial public offering on December 9, 2021, and is the third of up to six extensions permitted under the company's governing documents [1]

Company Overview - Globalink Investment Inc. is a special purpose acquisition company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [2] - The company has no restrictions on the industry or geographic region for its targets, but intends to focus on the medical technology and green energy sectors in North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) [2] Recent Developments - On July 3, 2025, Globalink deposited $0.15 per public share, totaling $10,890.15, into its trust account to extend the deadline for completing its initial business combination from July 9, 2025, to August 9, 2025 [1] - This extension marks the twenty-fifth extension since the company's initial public offering on December 9, 2021, and is the second of up to six extensions permitted under the company's governing documents [1]

Core Viewpoint - Globalink Investment Inc. has received approval from its stockholders to extend the deadline for completing its initial business combination until December 9, 2025, allowing for up to six monthly extensions at a cost of $0.15 per public share [1][2][4] Group 1: Amendments and Extensions - The stockholders approved amendments to the charter and trust agreement, enabling the extension of the deadline for the initial business combination from June 9, 2025, to December 9, 2025 [2][4] - Globalink can obtain up to six monthly extensions by depositing $0.15 per public share into its trust account prior to each extension [1][4] Group 2: Redemption Rights - The Charter Amendment triggered a right for public stockholders to demand redemption of their shares, resulting in 204,910 public shares being redeemed, leaving 72,601 public shares outstanding [3][4] Group 3: Company Overview - Globalink is a special purpose acquisition company formed to pursue mergers, share exchanges, asset acquisitions, and similar business combinations, with a focus on the technology industry, particularly in medical technology and green energy sectors across North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) [5]

Core Viewpoint - Globalink Investment Inc. has extended the deadline for its initial business combination by depositing $0.15 per public share into its trust account, marking the twenty-fourth extension since its IPO in December 2021 [1] Company Overview - Globalink is a special purpose acquisition company (SPAC) formed to pursue mergers, share exchanges, asset acquisitions, and similar business combinations without restrictions on industry or geographic region [2] - The company intends to target businesses in North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) specifically in the medical technology and green energy sectors [2]

Financial Performance - As of March 31, 2025, the company reported a net loss of $738,555, which included interest expense of $285,197 and general and administrative expenses of $270,256 [176]. - For the three months ended March 31, 2024, the company had a net loss of $375,307, driven by operating expenses of $603,471 and interest income of $342,667 [177]. - The company generates non-operating income from interest on proceeds held in a trust account, with interest income of $32,099 reported for the three months ended March 31, 2025 [175]. Initial Public Offering (IPO) - The company completed its IPO on December 9, 2021, raising gross proceeds of $100,000,000 from the sale of 10,000,000 units at $10.00 per unit [178]. - The company raised a total of $15,000,000 from the issuance of 1,500,000 units at a price of $10.00 per unit during the IPO [179]. - Offering costs for the IPO and the exercise of the underwriters' Over-allotment Option amounted to $6,887,896, including $2,300,000 in underwriting fees [180]. Business Combination and Merger Agreement - The company has extended the deadline to complete its initial business combination to June 9, 2025, having done so six times under its amended certificate of incorporation [164]. - The company entered into a Merger Agreement on January 30, 2024, with Alps Global Holding Pubco, which will result in Alps Holdco becoming a wholly-owned subsidiary of PubCo [165]. - The company expects to continue with the transactions outlined in the Merger Agreement despite the delisting of its securities [174]. Delisting and Compliance - The company received a delisting notice from Nasdaq on December 10, 2024, due to non-compliance with the requirement to complete a business combination within 36 months of its IPO [172]. - Following the delisting, the company's securities have been quoted on the OTC Pink market since December 17, 2024 [173]. Trust Account and Cash Management - As of March 31, 2025, cash held in the Trust Account was $3,561,690, with interest income of $32,099 for the three months ended March 31, 2025 [186]. - The company intends to use substantially all funds in the Trust Account to complete its business combination [187]. - The company had cash held outside the Trust Account amounting to $3,468 as of March 31, 2025, intended for evaluating target businesses [188]. Debt and Financing - As of March 31, 2025, the company had borrowed a total of $3,844,923 under various promissory notes, which includes $16,570 in additional interest expense [206]. - The company entered into multiple promissory notes with Public Gold Marketing Sdn Bhd, totaling $2,750,000 for working capital and extension fees, all repayable upon consummation of an initial business combination [190][191][192][193][194][196][197][198][199][201][202][203]. - The Company recorded a gain on modification of terms of promissory notes and advances from affiliates amounting to $880,656 [206]. Related Party Transactions - As of March 31, 2025, the aggregate principal amount owed to related parties in connection with promissory notes was $4,507,595, reflecting an increase from $4,445,458 as of December 31, 2024 [219]. - The net amount of the convertible notes related to the affiliate was $334,885, included in the consolidated balance sheet as of March 31, 2025 [209]. Going Concern and Future Capital Needs - The Company has until June 9, 2025, to complete the initial business combination, with substantial doubt raised about its ability to continue as a going concern if not completed [212]. - The Company may need to raise additional capital through loans or investments if the initial business combination is not consummated [210]. - The Company intends to complete a business combination before the mandatory liquidation date to avoid dissolution [212]. Accounting and Compliance - The Company is evaluating the impact of recent accounting pronouncements, including ASU 2023-09, which requires expanded disclosures of income taxes paid [228].

Group 1 - Globalink Investment Inc. has extended the deadline to complete its initial business combination from May 9, 2025, to June 9, 2025, by depositing $60,000 into its trust account [1] - This extension marks the twenty-third extension since the company's initial public offering on December 9, 2021, and the sixth of up to six extensions permitted under its governing documents [1] Group 2 - Globalink is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The company intends to pursue targets in North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) within the medical technology and green energy industries [2]

Company Overview - Globalink Investment Inc. is a special purpose acquisition company (SPAC) formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [2] - The company has no restrictions on the industry or geographic region for its targets, but it intends to focus on the medical technology and green energy sectors in North America, Europe, Southeast Asia, and Asia (excluding China, Hong Kong, and Macau) [2] Recent Developments - On April 8, 2025, Globalink deposited $60,000 into its trust account to extend the deadline for completing its initial business combination from April 9, 2025, to May 9, 2025 [1] - This extension marks the twenty-second extension since the company's initial public offering on December 9, 2021, and is the fifth of up to six extensions allowed under its governing documents [1]